Beacon Biomedical Inc. is a medical diagnostic development company and a Centers of Medicare and Medicaid Services (CMS) CLIA accredited laboratory services provider. The company focuses on creating easy, accurate, and affordable blood tests for early cancer detection. Their primary product, BeScreened CRC, is a blood-based test designed to help primary care providers screen patients for colorectal cancer, particularly those who are unwilling or unable to use traditional screening methods like colonoscopies. Beacon Biomedical operates in the healthcare diagnostics market, serving primary care providers and patients who need non-invasive cancer screening options. The company's business model revolves around developing laboratory-developed tests (LDTs) and offering them to healthcare practitioners and individuals. Revenue is generated through the sale of these diagnostic tests and related laboratory services.

Keywords: cancer detection, blood tests, colorectal cancer, primary care, non-invasive screening, healthcare diagnostics, laboratory services, LDT solutions, early detection, medical diagnostics.